These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23828107)

  • 1. Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device.
    Delgado Almandoz JE; Crandall BM; Scholz JM; Fease JL; Anderson RE; Kadkhodayan Y; Tubman DE
    AJNR Am J Neuroradiol; 2014 Jan; 35(1):128-35. PubMed ID: 23828107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device.
    Delgado Almandoz JE; Crandall BM; Scholz JM; Fease JL; Anderson RE; Kadkhodayan Y; Tubman DE
    J Neurointerv Surg; 2013 Nov; 5 Suppl 3():iii3-10. PubMed ID: 23314576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y12 Reaction Units: Effect on Hemorrhagic and Thromboembolic Complications in Patients With Cerebral Aneurysms Treated With the Pipeline Embolization Device.
    Daou B; Starke RM; Chalouhi N; Barros G; Tjoumakaris S; Rosenwasser RH; Jabbour P
    Neurosurgery; 2016 Jan; 78(1):27-33. PubMed ID: 26571145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study.
    Adeeb N; Griessenauer CJ; Foreman PM; Moore JM; Shallwani H; Motiei-Langroudi R; Alturki A; Siddiqui AH; Levy EI; Harrigan MR; Ogilvy CS; Thomas AJ
    Stroke; 2017 May; 48(5):1322-1330. PubMed ID: 28411263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value.
    Tan LA; Keigher KM; Munich SA; Moftakhar R; Lopes DK
    J Neurointerv Surg; 2015 Mar; 7(3):217-21. PubMed ID: 24553344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y12 hyporesponse (PRU>200) is not associated with increased thromboembolic complications in anterior circulation Pipeline.
    Bender MT; Lin LM; Colby GP; Lubelski D; Huang J; Tamargo RJ; Coon AL
    J Neurointerv Surg; 2017 Oct; 9(10):978-981. PubMed ID: 27599997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms.
    Delgado Almandoz JE; Kadkhodayan Y; Crandall BM; Scholz JM; Fease JL; Tubman DE
    J Neurointerv Surg; 2014 Dec; 6(10):767-73. PubMed ID: 24353331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining complication rates with flow diversion of anterior circulation aneurysms after introduction of the Pipeline Flex: analysis of a single-institution series of 568 cases.
    Colby GP; Bender MT; Lin LM; Beaty N; Caplan JM; Jiang B; Westbroek EM; Varjavand B; Campos JK; Huang J; Tamargo RJ; Coon AL
    J Neurosurg; 2018 Dec; 129(6):1475-1481. PubMed ID: 29327999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Hemorrhagic Complications following Pipeline Embolization Device Treatment of Intracranial Aneurysms: Results from the International Retrospective Study of the Pipeline Embolization Device.
    Brinjikji W; Lanzino G; Cloft HJ; Siddiqui AH; Kallmes DF
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2308-13. PubMed ID: 26251427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedural complexity independent of P2Y12 reaction unit (PRU) values is associated with acute in situ thrombosis in Pipeline flow diversion of cerebral aneurysms.
    Jiang B; Bender MT; Westbroek EM; Campos JK; Lin LM; Xu R; Tamargo RJ; Huang J; Colby GP; Coon AL
    Stroke Vasc Neurol; 2018 Sep; 3(3):169-175. PubMed ID: 30294473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and angiographic outcomes in patients with intracranial aneurysms treated with the pipeline embolization device: intra-procedural technical difficulties, major morbidity, and neurological mortality decrease significantly with increased operator experience in device deployment and patient management.
    Delgado Almandoz JE; Kayan Y; Tenreiro A; Wallace AN; Scholz JM; Fease JL; Milner AM; Mulder M; Uittenbogaard KM; Tenreiro-Picón O
    Neuroradiology; 2017 Dec; 59(12):1291-1299. PubMed ID: 28986614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of thrombotic complications and mass effect exacerbation after pipeline embolization: The significance of adenosine diphosphate inhibition, fluoroscopy time, and aneurysm size.
    Raychev R; Tateshima S; Vinuela F; Sayre J; Jahan R; Gonzalez N; Szeder V; Duckwiler G
    Interv Neuroradiol; 2016 Feb; 22(1):34-41. PubMed ID: 26537850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet Function Testing with a VerifyNow-Directed Personalized Antiplatelet Strategy and Associated Rates of Thromboembolic Complications After Pipeline Embolization for Complex Cerebral Aneurysms.
    Neyens R; Donaldson C; Andrews C; Kellogg R; Spiotta A
    World Neurosurg; 2020 Jun; 138():e674-e682. PubMed ID: 32194270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pipeline Embolization Device: Changes in Practice and Reduction of Complications in the Treatment of Anterior Circulation Aneurysms in a Multicenter Cohort.
    Dmytriw AA; Phan K; Salem MM; Adeeb N; Moore JM; Griessenauer CJ; Foreman PM; Shallwani H; Shakir H; Siddiqui AH; Levy EI; Davies JM; Harrigan MR; Thomas AJ; Ogilvy CS
    Neurosurgery; 2020 Feb; 86(2):266-271. PubMed ID: 30860254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device.
    McTaggart RA; Choudhri OA; Marcellus ML; Brennan T; Steinberg GK; Dodd RL; Do HM; Marks MP
    J Neurointerv Surg; 2015 Jun; 7(6):425-30. PubMed ID: 24739599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of platelet inhibition testing in patients undergoing Pipeline embolization of intracranial aneurysms.
    Miller TR; Wessell A; Jindal G; Malhotra A; Simard JM; Gandhi D
    J Neurointerv Surg; 2022 Jan; 14(1):. PubMed ID: 34078649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Branch Occlusion and Ischemic Complications with the Pipeline Embolization Device in the Treatment of Posterior Circulation Aneurysms.
    Adeeb N; Griessenauer CJ; Dmytriw AA; Shallwani H; Gupta R; Foreman PM; Shakir H; Moore J; Limbucci N; Mangiafico S; Kumar A; Michelozzi C; Zhang Y; Pereira VM; Matouk CC; Harrigan MR; Siddiqui AH; Levy EI; Renieri L; Marotta TR; Cognard C; Ogilvy CS; Thomas AJ
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1303-1309. PubMed ID: 29880475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms.
    Yamada NK; Cross DT; Pilgram TK; Moran CJ; Derdeyn CP; Dacey RG
    AJNR Am J Neuroradiol; 2007 Oct; 28(9):1778-82. PubMed ID: 17885244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms: evaluation of 66 consecutive cases with use of diffusion-weighted MR imaging.
    Soeda A; Sakai N; Sakai H; Iihara K; Yamada N; Imakita S; Nagata I
    AJNR Am J Neuroradiol; 2003 Jan; 24(1):127-32. PubMed ID: 12533341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Postprocedural Infarction and Antiplatelet Drug Resistance after Coiling for Unruptured Intracranial Aneurysms.
    Kim MS; Jo KI; Yeon JY; Kim JS; Kim KH; Jeon P; Hong SC
    AJNR Am J Neuroradiol; 2016 Jun; 37(6):1099-105. PubMed ID: 27056423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.